[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
May 20, 1998

Insulin Treatment for Type 2 Diabetes

Author Affiliations
 

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;279(19):1523-1526. doi:10.1001/jama.279.19.1523

To the Editor.—We are intrigued by the data of Dr Hayward and colleagues1on the treatment of type 2 diabetes by generalists, but we question their conclusions. They found mean hemoglobin A1c(HbA1c) levels in all patients to be 8%, better than in earlier studies. Sixteen percent of patients not taking insulin initially began insulin and had 0.9% lower HbA1c levels a year later. Despite this improvement, 60% of these patients failed to reach an 8% (0.08) HbA1clevel that indicated acceptable control. Short-term costs of starting insulin included a few more visits and tests and a 4-fold increase in glucose self-testing.

First Page Preview View Large
First page PDF preview
First page PDF preview
×